News & Updates

Patients with ST-segment elevation myocardial infarction (STEMI)-related cardiogenic shock may benefit from a significantly higher survival rate at 6 months through the routine use of a microaxial flow pump in combination with standard care as compared with standard care alone, as shown in a study presented at the recent ACC.24.

There is no short supply of standardized treatment protocols (STPs) for hypertension across the globe, but many of these can be further improved through interventions targeting alignment with the latest evidence-based guidelines and engagement with multiple stakeholders, suggests a study.

Ablation of ventricular tachycardia (VT) before placement of an implantable cardioverter-defibrillator (ICD) is associated with a reduced risk of appropriate ICD therapy or ventricular arrhythmia (VA)-related hospitalization in patients with ischaemic cardiomyopathy (ICM) and chronic total occlusion of an infarct-related artery (IRA-CTO), findings from the PREVENTIVE VT trial have shown.